Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial

por Horwitz, Steven, Zinzani, Pier Luigi, Bagot, Martine, Kim, Youn H., Moskowitz, Alison J., Porcu, Pierluigi, Dwyer, Karen, Sun, Wei, Herr, Fiona M., Scarisbrick, Julia
Publicado 2021

Long‐term disease control and safety with the anti‐CCR4 antibody mogamulizumab: Post‐hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T‐cell lympho...

por Bagot, Martine, Dalle, Stéphane, Sokol, Lubomir, Tsianakas, Athansios, Musiek, Amy, Ortiz‐Romero, Pablo L., Poligone, Brian, Duvic, Madeleine, Elmets, Craig, Leoni, Mollie, Dwyer, Karen, Ito, Takahiro, Herr, Fiona, Kim, Youn H.
Publicado 2022